4.6 Review

2′O-Ribose Methylation of Ribosomal RNAs: Natural Diversity in Living Organisms, Biological Processes, and Diseases

期刊

CELLS
卷 10, 期 8, 页码 -

出版社

MDPI
DOI: 10.3390/cells10081948

关键词

2 '-O-methylation; rRNA modification; ribosome; ribosome heterogeneity; RiboMeth-seq

资金

  1. ITMO Cancer [20CN063-00]
  2. INCa [2019-138]
  3. Ligue Nationale Contre le Cancer [PPE-2021]

向作者/读者索取更多资源

Recent studies have shown that ribosomes exhibit diverse compositions of rRNA 2'O-ribose methylation (2'Ome) depending on physiological and pathological contexts, indicating potential translational regulatory activities and functional specialization. The variations of rRNA 2'Ome may impact ribosome activity and contribute to the etiology of human diseases.
Recent findings suggest that ribosomes, the translational machineries, can display a distinct composition depending on physio-pathological contexts. Thanks to outstanding technological breakthroughs, many studies have reported that variations of rRNA modifications, and more particularly the most abundant rRNA chemical modification, the rRNA 2'O-ribose methylation (2'Ome), intrinsically occur in many organisms. In the last 5 years, accumulating reports have illustrated that rRNA 2'Ome varies in human cell lines but also in living organisms (yeast, plant, zebrafish, mouse, human) during development and diseases. These rRNA 2'Ome variations occur either within a single cell line, organ, or patient's sample (i.e., intra-variability) or between at least two biological conditions (i.e., inter-variability). Thus, the ribosomes can tolerate the absence of 2'Ome at some specific positions. These observations question whether variations in rRNA 2'Ome could provide ribosomes with particular translational regulatory activities and functional specializations. Here, we compile recent studies supporting the heterogeneity of ribosome composition at rRNA 2'Ome level and provide an overview of the natural diversity in rRNA 2'Ome that has been reported up to now throughout the kingdom of life. Moreover, we discuss the little evidence that suggests that variations of rRNA 2'Ome can effectively impact the ribosome activity and contribute to the etiology of some human diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

SETMAR Shorter Isoform: A New Prognostic Factor in Glioblastoma

Oriane Lie, Thierry Virolle, Mathieu Gabut, Claude Pasquier, Ilyess Zemmoura, Corinne Auge-Gouillou

Summary: This study investigates the expression of SETMAR protein in glioblastoma tissues and its potential as a prognostic marker. The results suggest that the level of S-SETMAR in the perilesional brain is associated with better survival outcomes in glioblastoma patients.

FRONTIERS IN ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

snoDB 2.0: an enhanced interactive database, specializing in human snoRNAs

Danny Bergeron, Hermes Paraqindes, Etienne Fafard-Couture, Gabrielle Deschamps-Francoeur, Laurence Faucher-Giguere, Philia Bouchard-Bourelle, Sherif Abou Elela, Frederic Catez, Virginie Marcel, Michelle S. Scott

Summary: snoDB is an interactive database providing up-to-date information on human small nucleolar RNAs (snoRNAs), including features, genomic location, conservation, host gene, snoRNA-RNA targets, and abundance. The second edition of snoDB introduces a new section on ribosomal RNA (rRNA) chemical modifications guided by snoRNAs, with easy navigation between different rRNA versions used in literature and experimentally measured modification levels. Additional information including snoRNA motifs, secondary structure prediction, snoRNA-protein interactions, and expression data in various tissues and cell lines has been included to enhance functional probing of snoRNA biology. Version 2.0 also features updated identifiers, more external resource links, and duplicate entry resolution.

NUCLEIC ACIDS RESEARCH (2023)

Article Pathology

Molecular Characterization of Adult Tumors Diagnosed as Cerebellar Glioblastomas Identifies Subgroups Associated With Prognosis

Thiebaud Picart, Delphine Poncet, Marc Barritault, Luc Bauchet, Sonia Zouaoui, Jacques Guyotat, Mathieu Gabut, Frederic Fina, Jerome Honnorat, Dominique Figarella-Branger, Johan Pallud, Francois Ducray, David Meyronet

Summary: The aim of this study was to identify subgroups of cerebellar glioblastoma (cGBM) based on targeted molecular analysis. Eighty-three cGBM cases were included and classified into 6 mutually exclusive subgroups associated with age at diagnosis and prognosis. MAPK pathway-activating alterations were found to be associated with a better outcome.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2023)

Article Oncology

Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group

Nour-El-Houda Mourksi, Cecile Dalban, Amelie Colombe-Vermorel, Laetitia Odeyer, Valentin Simioni, Jean-Sebastien Frenel, Michel Fabbro, Fernando Bazan, Sophie Abadie-Lacourtoisie, Elodie Coquan, Severine Martinez, Gwenaelle Garin, Severine Tabone-Eglinger, Isabelle Treilleux, Sylvie Chabaud, David Perol, Isabelle Ray-Coquard, Pierre-Etienne Heudel, Jean-Jacques Diaz, Virginie Marcel

Summary: The resistance of advanced hormone-dependent endometrial carcinoma to endocrine therapy is a global clinical issue. A recent study found that the combination of Vistusertib (a mTOR inhibitor) and Anastrozole (an aromatase inhibitor) improves progression-free rate compared to Anastrozole alone. This study evaluates the potential use of ribosome biogenesis (RiBi) factors as innovative markers for patient selection and treatment response prediction.

MOLECULAR ONCOLOGY (2023)

Article Multidisciplinary Sciences

RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cells

Sebastien Durand, Marion Bruelle, Fleur Bourdelais, Bigitha Bennychen, Juliana Blin-Gonthier, Caroline Isaac, Aurelia Huyghe, Sylvie Martel, Antoine Seyve, Christophe Vanbelle, Annie Adrait, Yohann Coute, David Meyronet, Frederic Catez, Jean-Jacques Diaz, Fabrice Lavial, Emiliano P. Ricci, Francois Ducray, Mathieu Gabut

Summary: The study reveals that RSL24D1 is highly expressed in both mouse and human pluripotent stem cells and is involved in the biogenesis of 60S subunits. Depletion of RSL24D1 impairs global translation, particularly of pluripotency factors and components from the Polycomb Repressive Complex 2 (PRC2), leading to altered self-renewal and lineage commitment choices in embryonic stem cells.

NATURE COMMUNICATIONS (2023)

Article Multidisciplinary Sciences

Machine learning-based detection of label-free cancer stem-like cell fate

Alexis J. Chambost, Nabila Berabez, Olivier Cochet-Escartin, Francois Ducray, Mathieu Gabut, Caroline Isaac, Sylvie Martel, Ahmed Idbaih, David Rousseau, David Meyronet, Sylvain Monnier

Summary: This study utilized microfluidics to optimize a deep learning algorithm for the accurate and rapid monitoring of isolated cancer stem-like cells under non-adherent conditions. The results demonstrate that the algorithm outperforms classical computer vision and shallow learning-based algorithms in terms of accuracy, while also being faster than cutting-edge convolutional neural networks (CNNs).

SCIENTIFIC REPORTS (2022)

Review Oncology

MiRNAs and snoRNAs in Bone Metastasis: Functional Roles and Clinical Potential

Margherita Puppo, Mariam Jaafar, Jean-Jacques Diaz, Virginie Marcel, Philippe Clezardin

Summary: This review discusses the roles of microRNAs and snoRNAs in the metastatic progression of cancer in bone. Dysregulation of microRNA and snoRNA expression in primary cancer cells leads to the acquisition of metastatic properties. Additionally, microRNAs and snoRNAs can act as intercellular mediators and remotely modulate the function of resident bone cells. Furthermore, the review explores the potential of microRNAs and snoRNAs as biomarkers and therapeutic targets in cancer treatments.

CANCERS (2023)

Article Psychiatry

HSV-1 cellular model reveals links between aggresome formation and early step of Alzheimer's disease

Marie Alexandra Albaret, Julien Textoris, Bastien Dalzon, Jeremy Lambert, Morgane Linard, Catherine Helmer, Sabine Hacot, Sandra E. Ghayad, Martial Ferreol, Hichem C. Mertani, Jean-Jacques Diaz

Summary: Many studies suggest a potential link between Alzheimer's disease and HSV-1 infection, but the molecular mechanisms behind this process are not yet fully understood.

TRANSLATIONAL PSYCHIATRY (2023)

Review Oncology

Challenges in glioblastoma research: focus on the tumor microenvironment

Andreas Bikfalvi, Cristine Alves da Costa, Tony Avril, Jean-Vianney Barnier, Luc Bauchet, Lucie Brisson, Pierre Francois Cartron, Helene Castel, Eric Chevet, Herve Chneiweiss, Anne Clavreul, Bruno Constantin, Valerie Coronas, Thomas Daubon, Monique Dontenwill, Francois Ducray, Natacha Entz-Werle, Dominique Figarella-Branger, Isabelle Fournier, Jean-Sebastien Frenel, Mathieu Gabut, Thierry Galli, Julie Gavard, Gilles Huberfeld, Jean-Philippe Hugnot, Ahmed Idbaih, Marie-Pierre Junier, Thomas Mathivet, Philippe Menei, David Meyronet, Celine Mirjolet, Fabrice Morin, Jean Mosser, Elisabeth Cohen-Jonathan Moyal, Veronique Rousseau, Michel Salzet, Marc Sanson, Giorgio Seano, Emeline Tabouret, Aurelie Tchoghandjian, Laurent Turchi, Francois M. Vallette, Somya Vats, Maite Verreault, Thierry Virolle

Summary: Glioblastoma (GBM) is a highly lethal brain tumor, and recent studies have emphasized the importance of the tumor microenvironment (TME) as a therapeutic target. However, a comprehensive understanding of the different cellular and molecular components involved in the GBM TME and their interactions is still needed for the development of more effective treatments. This review presents a comprehensive report on the GBM TME, combining the contributions of researchers and physicians in France, and provides a holistic view of the subject by describing the specific features of the GBM TME at the cellular, molecular, and therapeutic levels.

TRENDS IN CANCER (2023)

Correction Oncology

Isocitrate dehydrogenase wt and IDHmut adult-type diffuse gliomas display distinct alterations in ribosome biogenesis and 2'O-methylation of ribosomal RNA (Aug, noad140, 2023)

Hermes Paraqindes, Nour-El-Houda Mourksi, Samantha Ballesta, Jordan Hedjam, Fleur Bourdelais, Tanguy Fenouil, Thiebaud Picart, Frederic Catez, Theo Combe, Anthony Ferrari, Janice Kielbassa, Emilie Thomas, Laurie Tonon, Alain Viari, Valery Attignon, Marjorie Carrere, Jessie Perrossier, Stephane Giraud, Christophe Vanbelle, Mathieu Gabut, Danny Bergeron, Michelle S. Scott, Luis Castro Vega, Nathalie Magne, Emmanuelle Huillard, Marc Sanson, David Meyronet, Jean-Jacques Diaz, Francois Ducray, Virginie Marcel, Sebastien Durand

NEURO-ONCOLOGY (2023)

暂无数据